Valneva IPO Presentation Deck
VLA2001: Collaboration to Provide up to 190 Million Doses of M
Inactivated, Adjuvanted Vaccine to the UK
■ UK Government Agreement worth up to €1.4 Billion with Valneva to supply up
to 190 million doses¹
Including 100 million doses for 2021/2022
- UK Government retains options over a further 90 million doses for supply
between 2023 and 2025²
■ Agreement includes funding support for expansion of Valneva's
manufacturing facilities³ and clinical development in the UK
■ Ongoing dialogue with UK VTF regarding variant based vaccines
1 Valneva announces major COVID-19 vaccine partnership with U.K. government. 2 Valneva announces UK Government exercise of option for 40m doses of its Inactivated, Adjuvanted
COVID-19 vaccine, ³ Vaineva confirms participation in UK Government COVID-19 vaccine response program.
Valneva - Roadshow Presentation
April 2021View entire presentation